These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 27820659
1. No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative. Watts NB, Cauley JA, Jackson RD, LaCroix AZ, Lewis CE, Manson JE, Neuner JM, Phillips LS, Stefanick ML, Wactawski-Wende J, Crandall C, Women’s Health Initiative Investigators. J Clin Endocrinol Metab; 2017 Jan 01; 102(1):302-308. PubMed ID: 27820659 [Abstract] [Full Text] [Related]
2. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB. JAMA; 2013 Oct 02; 310(13):1353-68. PubMed ID: 24084921 [Abstract] [Full Text] [Related]
3. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, Sattari M, Prentice RL. JAMA; 2020 Jul 28; 324(4):369-380. PubMed ID: 32721007 [Abstract] [Full Text] [Related]
6. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women's Health Initiative Steering Committee. JAMA; 2004 Apr 14; 291(14):1701-12. PubMed ID: 15082697 [Abstract] [Full Text] [Related]
7. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J, WHI Investigators. JAMA; 2011 Apr 06; 305(13):1305-14. PubMed ID: 21467283 [Abstract] [Full Text] [Related]
8. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML, WHI Investigators. JAMA; 2008 Mar 05; 299(9):1036-45. PubMed ID: 18319414 [Abstract] [Full Text] [Related]
15. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ, Adams-Campbell LL, Nassir R, Lessin LS, Prentice RL. JAMA Oncol; 2015 Jun 05; 1(3):296-305. PubMed ID: 26181174 [Abstract] [Full Text] [Related]
16. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials. Swica Y, Warren MP, Manson JE, Aragaki AK, Bassuk SS, Shimbo D, Kaunitz A, Rossouw J, Stefanick ML, Womack CR. Menopause; 2018 Jul 05; 25(7):753-761. PubMed ID: 29381666 [Abstract] [Full Text] [Related]
17. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. Jiang X, Aragaki AK, Nudy M, Manson JE, Shadyab AH, Wild RA, Valdiviezo C, Gass M, Martin LW, Pan K, Stefanick ML, Robbins JA, Schnatz PF. Menopause; 2023 Jan 01; 30(1):28-36. PubMed ID: 36256926 [Abstract] [Full Text] [Related]
18. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. JAMA; 2007 Apr 04; 297(13):1465-77. PubMed ID: 17405972 [Abstract] [Full Text] [Related]
19. Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials. Chlebowski RT, Aragaki AK, Pan K, Haque R, Rohan TE, Song M, Wactawski-Wende J, Lane DS, Harris HR, Strickler H, Kauntiz AM, Runowicz CD. J Clin Oncol; 2024 Oct 20; 42(30):3537-3549. PubMed ID: 39173088 [Abstract] [Full Text] [Related]
20. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned. Manson JE, Bassuk SS, Kaunitz AM, Pinkerton JV. Menopause; 2020 Aug 20; 27(8):918-928. PubMed ID: 32345788 [Abstract] [Full Text] [Related] Page: [Next] [New Search]